Shares of Faron Pharmaceuticals Oy (LON:FARN – Get Free Report) crossed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of GBX 42.11 and traded as high as GBX 43. Faron Pharmaceuticals Oy shares last traded at GBX 40.90, with a volume of 233,242 shares trading hands.
Faron Pharmaceuticals Oy Trading Down 1.4%
The company has a market capitalization of £82.98 million, a P/E ratio of -1.85 and a beta of 1.12. The company has a debt-to-equity ratio of -133.35, a quick ratio of 1.09 and a current ratio of 0.84. The stock has a fifty day moving average of GBX 42.11 and a 200 day moving average of GBX 58.92.
Faron Pharmaceuticals Oy Company Profile
Faron (AIM: FARN, First North: FARON) is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline based on the receptors involved in regulation of immune response in oncology and organ damage. Clevegen (bexmarilimab), its investigative precision immunotherapy, is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation in various conditions, with potential across oncology, infectious disease and vaccine development.
Featured Stories
- Five stocks we like better than Faron Pharmaceuticals Oy
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
Receive News & Ratings for Faron Pharmaceuticals Oy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Faron Pharmaceuticals Oy and related companies with MarketBeat.com's FREE daily email newsletter.
